74 related articles for article (PubMed ID: 16490041)
1. The relationship between neuropeptide Y expression and headache in pituitary tumours.
Levy MJ; Classey JD; Maneesri S; Meeran K; Powell M; Goadsby PJ
Eur J Neurol; 2006 Feb; 13(2):125-9. PubMed ID: 16490041
[TBL] [Abstract][Full Text] [Related]
2. The association between calcitonin gene-related peptide (CGRP), substance P and headache in pituitary tumours.
Levy MJ; Classey JD; Maneesri S; Meeran K; Powell M; Goadsby PJ
Pituitary; 2004; 7(2):67-71. PubMed ID: 15761654
[TBL] [Abstract][Full Text] [Related]
3. No relationship between vasoactive intestinal polypeptide expression and headache in pituitary tumours.
Nathoo S; Classey JD; Levy MJ; Meeran K; Powell M; Goadsby PJ
Acta Neurol Scand; 2005 May; 111(5):317-22. PubMed ID: 15819711
[TBL] [Abstract][Full Text] [Related]
4. Immunolocalization of neuropeptide Y in human pituitary tumours.
Grouzmann E; Deruaz JP; Gomez F; Waeber G
Regul Pept; 1998 Sep; 75-76():89-92. PubMed ID: 9802397
[TBL] [Abstract][Full Text] [Related]
5. Expression of Neuropeptide Y and Its Relationship with Molecular and Morphological Changes in Human Pituitary Adenomas.
Jia R; Li M; Chang B; Chen L; Ma J
Cancer Biother Radiopharm; 2015 Dec; 30(10):411-9. PubMed ID: 26683132
[TBL] [Abstract][Full Text] [Related]
6. Gene expression of adrenomedullin, leptin, their receptors and neuropeptide Y in hormone-secreting and non-functioning pituitary adenomas, meningiomas and malignant intracranial tumours in humans.
Knerr I; Schuster S; Nomikos P; Buchfelder M; Dötsch J; Schoof E; Fahlbusch R; Rascher W
Neuropathol Appl Neurobiol; 2001 Jun; 27(3):215-22. PubMed ID: 11489141
[TBL] [Abstract][Full Text] [Related]
7. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and risk factors for headache associated with non-functioning pituitary adenomas.
Yu B; Ji N; Ma Y; Yang B; Kang P; Luo F
Cephalalgia; 2017 Apr; 37(4):348-355. PubMed ID: 27154998
[TBL] [Abstract][Full Text] [Related]
9. Expression of neuropeptide Y precursor-immunoreactivity in the hypothalamic dopaminergic tubero-infundibular system during lactation in rodents.
Ciofi P; Fallon JH; Croix D; Polak JM; Tramu G
Endocrinology; 1991 Feb; 128(2):823-34. PubMed ID: 1703484
[TBL] [Abstract][Full Text] [Related]
10. The expression of ghrelin in somatotroph and other types of pituitary adenomas.
Wasko R; Jaskula M; Kotwicka M; Andrusiewicz M; Jankowska A; Liebert W; Sowinski J
Neuro Endocrinol Lett; 2008 Dec; 29(6):929-38. PubMed ID: 19112387
[TBL] [Abstract][Full Text] [Related]
11. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
[TBL] [Abstract][Full Text] [Related]
12. Cranial autonomic symptoms in patients with pituitary adenoma presenting with headaches.
Wang SJ; Hung CW; Fuh JL; Lirng JF; Hwu CM
Acta Neurol Taiwan; 2009 Jun; 18(2):104-12. PubMed ID: 19673362
[TBL] [Abstract][Full Text] [Related]
13. Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours.
Bjellerup P; Theodorsson E; Jörnvall H; Kogner P
Br J Cancer; 2000 Jul; 83(2):171-6. PubMed ID: 10901366
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide-Y in the trout brain and pituitary: localization, characterization, and action on gonadotropin release.
Danger JM; Breton B; Vallarino M; Fournier A; Pelletier G; Vaudry H
Endocrinology; 1991 May; 128(5):2360-8. PubMed ID: 2019255
[TBL] [Abstract][Full Text] [Related]
15. Estrogen Induces Neuropeptide Y (NPY) Y1 receptor gene expression and responsiveness to NPY in gonadotrope-enriched pituitary cell cultures.
Hill JW; Urban JH; Xu M; Levine JE
Endocrinology; 2004 May; 145(5):2283-90. PubMed ID: 14726443
[TBL] [Abstract][Full Text] [Related]
16. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
17. Evidence for neuropeptide Y synthesis in the rat anterior pituitary and the influence of thyroid hormone status: comparison with vasoactive intestinal peptide, substance P, and neurotensin.
Jones PM; Ghatei MA; Steel J; O'Halloran D; Gon G; Legon S; Burrin JM; Leonhardt U; Polak JM; Bloom SR
Endocrinology; 1989 Jul; 125(1):334-41. PubMed ID: 2472269
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y modulates the binding of a gonadotropin-releasing hormone (GnRH) analog to anterior pituitary GnRH receptor sites.
Parker SL; Kalra SP; Crowley WR
Endocrinology; 1991 May; 128(5):2309-16. PubMed ID: 1850349
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of neurogenins and NeuroD1 in human pituitary tumours.
Fratticci A; Grieco FA; Spilioti C; Giangaspero F; Ventura L; Esposito V; Piccirilli M; Santoro A; Gulino A; Cantore G; Alesse E; Jaffrain-Rea ML
J Endocrinol; 2007 Sep; 194(3):475-84. PubMed ID: 17761887
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide-Y stimulates growth hormone and gonadotropin-II secretion in the goldfish pituitary: involvement of both presynaptic and pituitary cell actions.
Peng C; Chang JP; Yu KL; Wong AO; Van Goor F; Peter RE; Rivier JE
Endocrinology; 1993 Apr; 132(4):1820-9. PubMed ID: 8462479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
